Recombinant human erythropoietin reduces ischemic acute kidney injury but does not stop progression to chronic kidney disease

Bennett, N., Colditz, P., Gobe, G. C., Johnson, D., Patel, J. and Vesey, D. A. (2008). Recombinant human erythropoietin reduces ischemic acute kidney injury but does not stop progression to chronic kidney disease. In: Nephrology. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Newcastle, Australia, (A135-A135). 6-10 September 2008. doi:10.1111/j.1440-1797.2008.001013.x


Author Bennett, N.
Colditz, P.
Gobe, G. C.
Johnson, D.
Patel, J.
Vesey, D. A.
Title of paper Recombinant human erythropoietin reduces ischemic acute kidney injury but does not stop progression to chronic kidney disease
Conference name 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology
Conference location Newcastle, Australia
Conference dates 6-10 September 2008
Proceedings title Nephrology   Check publisher's open access policy
Publisher Australian and New Zealand Society of Nephrology (ANZSN)
Publication Year 2008
Sub-type Published abstract
DOI 10.1111/j.1440-1797.2008.001013.x
ISSN 1320-5358
1440-1797
Volume 13
Issue s3
Start page A135
End page A135
Total pages 1
Language eng
Q-Index Code EX
Q-Index Status Provisional Code
Institutional Status Unknown
Additional Notes Abstract number: 135

 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Scopus Citation Count Cited 0 times in Scopus Article
Google Scholar Search Google Scholar
Created: Mon, 15 Mar 2010, 23:47:13 EST by Laura McTaggart on behalf of Faculty Of Health Sciences